Quality of decision aids developed for women at average risk of breast cancer eligible for mammographic screening: Systematic review and assessment according to the International Patient Decision Aid Standards instrument.
breast cancer
cancer screening
decision aid
informed decision making
mammography
shared decision making
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
15 06 2020
15 06 2020
Historique:
received:
07
12
2019
revised:
20
02
2020
accepted:
29
02
2020
pubmed:
9
4
2020
medline:
10
4
2021
entrez:
9
4
2020
Statut:
ppublish
Résumé
Mammographic screening contributes to a reduction in specific mortality, but it has disadvantages. Decision aids are tools designed to support people's decisions. Because these aids influence patient choice, their quality is crucial. The objective of the current study was to conduct a systematic review of decision aids developed for women eligible for mammographic screening who have an average breast cancer risk and to assess the quality of these aids. The systematic review included articles published between January 1, 1997, and August 1, 2019, in the PubMed, Embase, Cochrane, and PsycInfo databases. The studies were reviewed independently by 2 reviewers. Any study containing a decision aid for women eligible for mammographic screening with an average breast cancer risk was included. Two double-blind reviewers assessed the quality of the selected decision aids using the International Patient Decision Aid Standards instrument, version 3 (IPDASi). Twenty-three decision aids were extracted. Classification of decision aid quality using the IPDASi demonstrated large variations among the decision aids (maximum IPDASi score, 188; mean ± SD score, 132.6 ± 23.8; range, 85-172). Three decision aids had high overall scores. The 3 best-rated dimensions were disclosure (maximum score, 8; mean score, 6.8), focusing on transparency; information (maximum score, 32; mean score, 26.1), focusing on the provision of sufficient details; and probabilities (maximum score, 32; mean score 25), focusing on the presentation of probabilities. The 3 lowest-rated dimensions were decision support technology evaluation (maximum score, 8; mean score, 4.3), focusing on the effectiveness of the decision aid; development (maximum score, 24; mean score, 12.6), evaluating the development process; and plain language (maximum score, 4; mean score, 1.9), assessing appropriateness for patients with low literacy. The results of this review identified 3 high-quality decision aids for breast cancer screening.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2765-2774Informations de copyright
© 2020 American Cancer Society.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
Myers ER, Moorman P, Gierisch JM, et al. Benefits and harms of breast cancer screening: a systematic review. JAMA. 2015;314:1615-1634.
Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2009;4:CD001877.
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast-cancer screening-viewpoint of the IARC Working Group [internet]. N Engl J Med. 2015;372:2353-2358.
Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311:1327-1335.
Mandrik O, Zielonke N, Meheus F, et al. Systematic reviews as a ‘lens of evidence’: determinants of benefits and harms of breast cancer screening. Int J Cancer. 2019;145:994-1006.
Salisbury H. Helen Salisbury: Should I persuade patients to have mammograms? BMJ. 2019;365:11409.
Briss P, Rimer B, Reilley B, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26:67-80.
Murray E, Charles C, Gafni A. Shared decision-making in primary care: tailoring the Charles et al model to fit the context of general practice. Patient Educ Couns. 2006;62:205-211.
Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD0001431.
O’Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;3:CD001431.
Caverly TJ, Hayward RA, Reamer E, et al. Presentation of benefits and harms in US Cancer screening and prevention guidelines: systematic review. J Natl Cancer Inst. 2016;108:djv436.
Keating NL, Pace LE. Breast cancer screening in 2018: time for shared decision making. JAMA. 2018;319:1814-1815.
Elwyn G, O’Connor AM, Bennett C, et al. Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One. 2009;4:e4705.
Abstrackr. Software: Abstrackr. Brown University School of Public Health. Accessed February 1, 2020. https://www.brown.edu/public-health/cesh/resources/software
Wong IO, Lam WW, Wong CN, Cowling BJ, Leung GM, Fielding R. Towards informed decisions on breast cancer screening: development and pilot testing of a decision aid for Chinese women. Patient Educ Couns. 2015;98:961-969.
Baena-Canada JM, Rosado-Varela P, Exposito-Alvarez I, Gonzalez-Guerrero M, Nieto-Vera J, Benitez-Rodriguez E. Using an informed consent in mammography screening: a randomized trial. Cancer Med. 2015;4:1923-1932.
Webster P, Austoker J. Does the English Breast Screening Programme's information leaflet improve women's knowledge about mammography screening? A before and after questionnaire survey. J Public Health (Oxf). 2007;29:173-177.
Toledo-Chavarri A, Rue M, Codern-Bove N, et al. A qualitative study on a decision aid for breast cancer screening: views from women and health professionals. Eur J Cancer Care. 2017;26:e12660.
Reder M, Kolip P. Does a decision aid improve informed choice in mammography screening? Study protocol for a randomized controlled trial. BMC Womens Health (Larchmt). 2015;15:53.
Bourmaud A, Soler-Michel P, Oriol M, et al. Decision aid on breast cancer screening reduces attendance rate: results of a large-scale, randomized, controlled study by the DECIDEO group. Oncotarget. 2016;7:12885-12892.
Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330:936.
Fuller MS, Lee CI, Elmore JG. Breast cancer screening: an evidence-based update. Med Clin North Am. 2015;99:451-468.
Hersch J, Barratt A, Jansen J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015;385:1642-1652.
Marshall T. Informed consent for mammography screening: modelling the risks and benefits for American women. Health Expect. 2005;8:295-305.
Marshall T, Adab P. Informed consent for breast screening: what should we tell women? J Med Screen. 2003;10:22-26.
Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med. 2007;167:2039-2046.
Pasternack I, Saalasti-Koskinen U, Makela M. Decision aid for women considering breast cancer screening. Int J Technol Assess Health Care. 2011;27:357-362.
Petrova D, Garcia-Retamero R, Cokely ET. Understanding the harms and benefits of cancer screening: a model of factors that shape informed decision making. Med Decis Mak. 2015;35:847-858.
Rimer BK, Halabi S, Skinner CS, et al. The short-term impact of tailored mammography decision-making interventions. Patient Educ Couns. 2001;43:271-287.
Schonberg MA, Kistler CE, Nekhlyudov L, et al. Evaluation of a mammography screening decision aid for women aged 75 and older: protocol for a cluster-randomized controlled trial. J Clin Trials. 2014;4:191.
Eden KB, Scariati P, Klein K, et al. Mammography decision aid reduces decisional conflict for women in their forties considering screening. J Womens Health (Larchmt). 2015;24:1013-1020.
Elkin EB, Pocus VH, Mushlin AI, Cigler T, Atoria CL, Polaneczky MM. Facilitating informed decisions about breast cancer screening: development and evaluation of a web-based decision aid for women in their 40s. BMC Med Inform Decis Mak. 2017;17:29.
Healthwise. Breast Cancer Screening: When Should I Start Having Mammograms? The Ottawa Hospital Research Institute; 2016. Accessed February 1, 2020. https://decisionaid.ohri.ca/AZsumm.php?ID=1389
Keevil J. Breast Cancer Screening Decision Support Tool. The Ottawa Hospital Research Institute; 2017. Accessed February 1, 2020. https://decisionaid.ohri.ca/AZsumm.php?ID=1881
Mathieu E, Barratt AL, McGeechan K, Davey HM, Howard K, Houssami N. Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Couns. 2010;81:63-72.
Nekhlyudov L, Braddock CH Jr. An approach to enhance communication about screening mammography in primary care. J Womens Health (Larchmt). 2009;18:1403-1412.
Ancker JS, Senathirajah Y, Kukafka R, Starren JB. Design features of graphs in health risk communication: a systematic review. J Am Med Inform Assoc. 2006;13:608-618.
Trevena LJ, Zikmund-Fisher BJ, Edwards A, et al. Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak. 2013;13(suppl 2):S7.
Timmermans DR, Ockhuysen-Vermey CF, Henneman L. Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions. Patient Educ Couns. 2008;73:443-447.
Lipkus IM, Samsa G, Rimer BK. General performance on a numeracy scale among highly educated samples. Med Decis Mak. 2001;21:37-44.
Durand MA, Carpenter L, Dolan H, et al. Do interventions designed to support shared decision-making reduce health inequalities? A systematic review and meta-analysis. PLoS One. 2014;9:e94670.
Enard KR, Dolan Mullen P, Kamath GR, Dixon NM, Volk RJ. Are cancer-related decision aids appropriate for socially disadvantaged patients? A systematic review of US randomized controlled trials. BMC Med Inform Decis Mak. 2016;16:64.
McCaffery KJ, Holmes-Rovner M, Smith SK, et al. Addressing health literacy in patient decision aids. BMC Med Inform Decis Mak. 2013;13(suppl 2):S10.
Lyratzopoulos G, Abel GA, Brown CH, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol. 2013;24:843-850.
Smith SK, Trevena L, Simpson JM, Barratt A, Nutbeam D, McCaffery KJ. A decision aid to support informed choices about bowel cancer screening among adults with low education: randomised controlled trial. BMJ. 2010;341:c5370.
Durand MA, Alam S, Grande SW, Elwyn G. ‘Much clearer with pictures’: using community-based participatory research to design and test a Picture Option Grid for underserved patients with breast cancer. BMJ Open. 2016;6:e010008.
Coorey G, Peiris D, Usherwood T, Neubeck L, Mulley J, Redfern J. Persuasive design features within a consumer-focused eHealth intervention integrated with the electronic health record: a mixed methods study of effectiveness and acceptability. PLoS One. 2019;14:e0218447.
Kruse CS, Argueta DA, Lopez L, Nair A. Patient and provider attitudes toward the use of patient portals for the management of chronic disease: a systematic review. J Med Internet Res. 2015;17:e40.
Kruse CS, Bolton K, Freriks G. The effect of patient portals on quality outcomes and its implications to meaningful use: a systematic review. J Med Internet Res. 2015;17:e44.
Peate M, Smith SK, Pye V, et al. Assessing the usefulness and acceptability of a low health literacy online decision aid about reproductive choices for younger women with breast cancer: the aLLIAnCE pilot study protocol. Pilot Feasibility Stud. 2017;3:31.
Politi MC, Adsul P, Kuzemchak MD, Zeuner R, Frosch DL. Clinicians' perceptions of digital vs. paper-based decision support interventions. J Eval Clin Pract. 2015;21:175-179.
Davey C, White V, Gattellari M, Ward JE. Reconciling population benefits and women's individual autonomy in mammographic screening: in-depth interviews to explore women's views about ‘informed choice’. Aust NZ J Public Health. 2005;29:69-77.
Montori VM, LeBlanc A, Buchholz A, Stilwell DL, Tsapas A. Basing information on comprehensive, critically appraised, and up-to-date syntheses of the scientific evidence: a quality dimension of the International Patient Decision Aid Standards. BMC Med Inform Decis Mak. 2013;13(suppl 2):S5.
Feldman-Stewart D, Brennenstuhl S, McIssac K, et al. A systematic review of information in decision aids. Health Expect. 2007;10:46-61.
Rosenbaum L. “Misfearing”-culture, identity, and our perceptions of health risks. N Engl J Med. 2014;370:595-597.
Biesecker BB, Schwartz MD, Marteau TM. Enhancing informed choice to undergo health screening: a systematic review. Am J Health Behav. 2013;37:351-359.
van Agt HM, Korfage IJ, Essink-Bot ML. Interventions to enhance informed choices among invitees of screening programmes-a systematic review. Eur J Public Health. 2014;24:789-801.
Ivlev I, Hickman EN, McDonagh MS, Eden KB. Use of patient decision aids increased younger women's reluctance to begin screening mammography: a systematic review and meta-analysis. J Gen Intern Med. 2017;32:803-812.
DuBenske LL, Schrager SB, Hitchcock ME, et al. Key elements of mammography shared decision-making: a scoping review of the literature. J Gen Intern Med. 2018;33:1805-1814.
Jimbo M, Rana GK, Hawley S, et al. What is lacking in current decision aids on cancer screening? CA Cancer J Clin. 2013;63:193-214.
Howick J, Chalmers I, Glasziou P, et al; Oxford Centre for Evidence-Based Medicine (OCEBM), Levels of Evidence Working Group. The 2011 Oxford Levels of Evidence. OCEBM' 2011.